Lamivudine 00904-6583-04

Package NDC

00904-6583-04

Manufacturer: Major Pharmaceuticals
Dosage Form: Tablet, Film Coated
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: December 2, 2011
Listing Expires: December 31, 2027
Application: ANDA091606

Need to source Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Lamivudine	150 mg/1

Drug Class

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Selected Package

00904-6583-04Selected

30 BLISTER PACK in 1 CARTON (0904-6583-04) / 1 TABLET, FILM COATED in 1 BLISTER PACK